University of Virginia
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1819-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.virginia.edu
Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma
- First Posted Date
- 2012-02-02
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 35
- Registration Number
- NCT01524692
- Locations
- 🇺🇸
University of Virginia Health System, Charlottesville, Virginia, United States
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer
Early Phase 1
Completed
- Conditions
- First Posted Date
- 2011-11-30
- Last Posted Date
- 2016-05-13
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 12
- Registration Number
- NCT01482728
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Study of Menstrual Irregularities and Endometrial Pathology in Women Undergoing Bariatric Surgery
Completed
- Conditions
- First Posted Date
- 2011-11-17
- Last Posted Date
- 2015-06-02
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 100
- Registration Number
- NCT01473186
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-11-11
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT01470807
- Locations
- 🇮🇹
University of Padova, Padova, Italy
A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)
- First Posted Date
- 2011-11-10
- Last Posted Date
- 2015-07-31
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 16
- Registration Number
- NCT01469715
- Locations
- 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
Double-blind Placebo-controlled Pilot Study of Sirolimus in Idiopathic Pulmonary Fibrosis (IPF)
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2021-03-22
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 32
- Registration Number
- NCT01462006
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2014-06-19
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT01447992
- Locations
- 🇮🇹
Azienda Ospedaliera E Universita Degli Study Di Padova, Padova, Veneto, Italy
Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier
Early Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2012-11-29
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 5
- Registration Number
- NCT01447979
- Locations
- 🇫🇷
Centre d'Investigation Clinique CHU Montpellier, Montpellier, France
Reducing Alcohol Exposed Pregnancy Risk: EARLY Randomized Controlled Trial
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-10-05
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 232
- Registration Number
- NCT01446653
- Locations
- 🇺🇸
UVA CARE, Richmond, Virginia, United States
Insulin Sensitivity, Impaired Counterregulation, and Glucose Variability
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-23
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- University of Virginia
- Target Recruit Count
- 35
- Registration Number
- NCT01439672
- Locations
- 🇺🇸
University of Virginia, Center for Diabetes Technology, Charlottesville, Virginia, United States
© Copyright 2024. All Rights Reserved by MedPath